A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

Abstract Background The aim of this study is to demonstrate that capecitabine metronomic chemotherapy is non-inferior to capecitabine conventional chemotherapy as maintenance treatment, in patients who have responded to 16–18 weeks first-line chemotherapy in metastatic colorectal cancer (mCRC). Meth...

Full description

Bibliographic Details
Main Authors: Min Shi, Tao Ma, Wenqi Xi, Jinling Jiang, Junwei Wu, Chenfei Zhou, Chen Yang, Zhenggang Zhu, Jun Zhang
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Trials
Subjects:
Metronomic chemotherapy
Capecitabine
Maintenance treatment
Metastatic colorectal cancer
Online Access:http://link.springer.com/article/10.1186/s13063-020-4194-6

Internet

http://link.springer.com/article/10.1186/s13063-020-4194-6

Similar Items